Dosage Cups Market Report 2026

The dosage cups market size has grown strongly in recent years. It will grow from $1.54 billion in 2025 to $1.62 billion in 2026 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to growing consumption of liquid oral medications, increasing awareness regarding accurate medication dosing, rising adoption of OTC pharmaceutical products, expansion of hospital and clinical healthcare infrastructure, advancements in medical packaging and dispensing solutions.

The dosage cups market size is expected to see strong growth in the next few years. It will grow to $2.02 billion by 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing demand for sustainable biodegradable dosage cups, rising focus on patient safety and medication accuracy, growing adoption of customized pharmaceutical packaging solutions, expansion of home healthcare and self medication practices, increasing investment in automated pharmaceutical manufacturing systems. Major trends in the forecast period include increasing adoption of calibrated dosage cups for accurate medication administration, rising demand for biodegradable and eco friendly dosage cup materials, growing use of printed measurement markings for improved dosage accuracy, expansion of reusable dosage cups for long term healthcare applications, increasing preference for tamper resistant and spill proof dosage cup designs.

The growing demand for precise medication dosing is expected to propel the expansion of the dosage cups market going forward. Accurate medication dosing refers to the exact measurement and administration of the appropriate quantity of a drug to a patient, ensuring effective therapeutic outcomes while minimizing the risk of adverse or harmful effects. The increasing need for precise dosing is primarily driven by the rising occurrence of medication errors, as improper measurement of liquid medicines can lead to overdosing or underdosing, which may cause severe adverse health outcomes. The escalation in medication dosing errors is contributing to a higher requirement for standardized and calibrated liquid-measuring tools that support patients and caregivers in delivering accurate medicine quantities. For instance, in December 2024, according to the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based federal agency, in 2023, the United States recorded approximately 7.6 million drug-related emergency department visits, equating to a rate of 2,266 visits per 100,000 people. Therefore, the rising demand for accurate medication dosing is driving the growth of the dosage cups market.

The expansion of home healthcare and self-medication is expected to propel the growth of the dosage cups market going forward. Home healthcare refers to a broad range of medical and supportive services delivered to patients in their residences, while self-medication involves individuals independently managing their health conditions using over-the-counter or prescribed medicines without direct clinical supervision. The growth of home healthcare and self-medication is primarily contributing from the increasing aging population, as older adults are progressively managing multiple chronic conditions at home, leading to greater reliance on home-based treatment and self-administered medication routines. The rising shift toward home-based care and independent medication management is further supporting demand for dosage cups, as these tools are essential for accurately measuring and administering liquid or oral medications safely in home settings. For instance, in August 2025, according to the U. S. Bureau of Labor Statistics, a US-based federal agency, the employment of home health and personal care aides is projected to grow by 17% between 2024 and 2034, significantly outpacing the average growth rate across all occupations, with approximately 765,800 job openings projected annually during this period. Therefore, the expansion of home healthcare and self-medication is driving the growth of the dosage cups market.

In December 2025, AptarGroup, Inc., a US-based pharmaceutical packaging and drug delivery solutions company, acquired Sommaplast for an undisclosed amount. Through this acquisition, Aptar sought to broaden its oral dosing and pharmaceutical packaging portfolio by enhancing its expertise in dispensing and dosing solutions, including closures, droppers, and dosing cups, in order to better serve expanding healthcare and over-the-counter markets. Sommaplast is a Brazil-based pharmaceutical packaging company specializing in oral dosing solutions such as closures, droppers, dispensers, and dosing cups used for liquid medication administration.

Major companies operating in the dosage cups market are Medline Industries LP, Amcor plc, Berry Global Inc., Eastman Chemical Company, Silgan Holdings Inc., AptarGroup Inc., Gerresheimer AG, Comar LLC, Bormioli Pharma S. p. A., Adelphi Healthcare Packaging Limited, Mikart LLC, Qosina Corp., O. Berk Company LLC, Alpha Packaging Holdings Inc., Lyne Laboratories Inc., Hammarplast Medical AB, GPC Medical Ltd, Sensoplast Packmitteltechnik GmbH, Parekhplast India Limited, UD Pharma Rubber Products Private Limited, Yasharyn Packaging Private Limited.

North America was the largest region in the dosage cups market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dosage cups market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the dosage cups market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dosage cups market consists of sales of graduated medicine dosing cups, oral liquid measuring cups, pediatric dosing cups, and pharmacy dispensing cups. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.